EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, IVERIC bio's Enterprise Value is $5,010.02 Mil.
IVERIC bio's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2023 was $-177.71 Mil. Therefore, IVERIC bio's EV-to-FCF for today is -28.19.
The historical rank and industry rank for IVERIC bio's EV-to-FCF or its related term are showing as below:
ISEE'
s EV-to-FCF Range Over the Past 10 Years
Min: -79.08 Med: -1.32 Max: 17.62
Current: -28.19
During the past 12 years, the highest EV-to-FCF of IVERIC bio was 17.62. The lowest was -79.08. And the median was -1.32.
ISEE's EV-to-FCF is not ranked
in the Biotechnology industry.
Industry Median: 6.365
vs ISEE: -28.19
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-13), IVERIC bio's stock price is $39.95.
IVERIC bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 was $-1.760. Therefore, IVERIC bio's PE Ratio for today is At Loss.
IVERIC bio EV-to-FCF Historical Data
The historical data trend for IVERIC bio's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, IVERIC bio's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVERIC bio's EV-to-FCF Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, IVERIC bio's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where IVERIC bio's EV-to-FCF falls into.
IVERIC bio EV-to-FCF Calculation
IVERIC bio's EV-to-FCF for today is calculated as:
IVERIC bio's current Enterprise Value is $5,010.02 Mil.
IVERIC bio's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-177.71 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVERIC bio (NAS:ISEE) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
IVERIC bio's share price for today is $39.95.
IVERIC bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.760.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
IVERIC bio EV-to-FCF Related Terms
Thank you for viewing the detailed overview of IVERIC bio's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases, or IRDs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ISEE has been successfully added to your 